Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients
- 4 March 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Photochemical & Photobiological Sciences
- Vol. 10 (5), 817-821
- https://doi.org/10.1039/c0pp00306a
Abstract
We report our preliminary results of a pilot clinical trial of late-stage breast cancer patients treated by laser immunotherapy (LIT), a local intervention using an 805 nm laser for non-invasive irradiation, indocyanine green for selective thermal effect, and immunoadjuvant (glycated chitosan) for immunological stimulation. Ten breast cancer patients were enrolled in this study; all patients were considered to be out of other available treatment options. Toxicity was individually evaluated through physical exams and laboratory tests. Adverse reactions only occurred in the area of treatment due to photothermal injury and local administration of immunoadjuvant. No grade 3 or 4 side effects were observed. Treatment efficacy of LIT was also evaluated by physical examination and tomography. In 8 patients available for evaluation, the objective response rate was 62.5% and the clinical beneficial response rate was 75%. While the study is still ongoing, the initial outcomes of this clinical trial show that LIT is well tolerated and is promising in the treatment of metastatic breast cancer.Keywords
This publication has 26 references indexed in Scilit:
- Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancerBreast Cancer Research and Treatment, 2010
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response CriteriaClinical Cancer Research, 2009
- Hyperthermia on immune regulation: A temperature’s storyCancer Letters, 2008
- Acute Toxicity and 2-year Adverse Effects of 30 Gy in Five Fractions over 15 Days to Whole Breast after Local Excision of Early Breast CancerClinical Oncology, 2008
- Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanomaInternational Journal of Cancer, 2007
- Phase I/II Trial of an Allogeneic Cellular Immunotherapy in Hormone-Naïve Prostate CancerClinical Cancer Research, 2006
- Breast Cancer Staging: Working With the Sixth Edition of the AJCC Cancer Staging ManualCA: A Cancer Journal for Clinicians, 2006
- Induced antitumor immunity against DMBA-4 metastatic mammary tumors in rats using laser immunotherapyInternational Journal of Cancer, 2003
- Laser Immunotherapy: A Novel Treatment Modality for Metastatic TumorsMolecular Biotechnology, 2003
- Antitumor immunity induced by laser immunotherapy and its adoptive transfer.2001